FG’s Biovaccines Nigeria Ltd to commence vaccine production by Q2 2023
Nigeria’s Biovaccines Nigeria Limited (BVNL) is set to begin production of vaccines before second quarter of 2023
Nigeria’s Biovaccines Nigeria Limited (BVNL) is set to begin production of vaccines before second quarter of 2023
MAY & BAKER NIGERIA PLC released its unaudited financial results for the third quarter of the year ended 30th of September 2021. Revenue ...
In this article, we bring you some of Nigeria’s leading penny stocks outperforming the country’s inflation rate of 18.12%.
May & Baker Nigeria Plc has announced the signing of a manufacturing agreement with Sanofi Nigeria Limited.
May & Baker Nigeria Plc has announced the exit of its Director and Chairman of Board of Directors, Theophilus Danjuma.
@nsenigeria ended Tuesday’s trading session in negative territory. The All Share Index closed at 27,527.40 basis points, down 0.51%. Year ...
Shareholders of @maybakernigeria have approved a dividend payment of N345.04 million for the financial year ended 31st December 2018.
Following the divestment of its foods business which, on average, accounts for 23.36% of its revenue, May & Baker Nigeria ...
May & Baker Nigeria Plc have just recently disclosed its financial statement for Q1 period ended March 31st. Below are the ...
The Management and Board of May & Baker Plc, today, announced dividend payment of 20 kobo per 50 kobo share.